Lipoprotein X causes renal disease in LCAT deficiency

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Ossoli, Alice ^a   Neufeld, Edward B ^b   Thacker, Seth G ^b   Vaisman, Boris ^b   Pryor, Milton ^b   Freeman, Lita A ^b   Brantner, Christine A ^b   Baranova, Irina ^c   Francone, Nicolás O ^b   Demosky, Stephen J ^b   Vitali, Cecilia ^a   Locatelli, Monica ^d   Abbate, Mauro ^d   Zoja, Carlamaria ^d   Franceschini, Guido ^a   Calabresi, Laura ^a   Remaley, Alan T ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; LIPOPROTEIN X; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE A2; VIMENTIN; INTERLEUKIN-6, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSKELETON; ELECTRON MICROSCOPY; ENDOCYTOSIS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GLOMERULAR CAPILLARY ENDOTHELIAL CELL; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFANT; KIDNEY DISEASE; LCAT MOUSE; LECITHIN CHOLESTEROL ACYLTRANSFERASE DEFICIENCY; LYSOSOME; MESANGIUM CELL; MOUSE; NEPHROTOXICITY; NONHUMAN; PINOCYTOSIS; PLASMA CLEARANCE; PODOCYTE; PROTEINURIA; REGULATOR GENE; SCANNING ELECTRON MICROSCOPY; TMSB10 GENE; TRANSMISSION ELECTRON MICROSCOPY; VIM GENE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENETICS; MESANGIUM; METABOLIC CLEARANCE RATE; METABOLISM; PATHOLOGY; SECRETION (PROCESS); ULTRASTRUCTURE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; APOLIPOPROTEIN A-I; CELLS, CULTURED; CYTOSKELETON; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GLOMERULAR BASEMENT MEMBRANE; GLOMERULAR MESANGIUM; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; KIDNEY GLOMERULUS; LECITHIN CHOLESTEROL ACYLTRANSFERASE DEFICIENCY; LIPOPROTEIN-X; LIPOPROTEINS, HDL; LYSOSOMES; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPASES A2; PINOCYTOSIS; PODOCYTES; PROTEINURIA;

EID: 84960430223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150083     Document Type: Article

References (59)

1. Jonas A (2000) Lecithin cholesterol acyltransferase. Biochim Biophys Acta 1529: 245-256. PMID: 11111093
2. Santamarina-Fojo S HJ, Assmann G, Brewer HB Jr (2001): Lecithin cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR BA, Sly WS, Valle D editor. The Metabolic and Molecular Bases of Inherited Diseases New York: McGraw-Hill. pp. pp 2817-2833.
3. Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, et al. (2005) The molecular basis of lecithin: cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25: 1972-1978. PMID: 15994445
4. Asztalos BF, Schaefer EJ, Horvath KV, Yamashita S, Miller M, et al. (2007) Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res 48: 592-599. PMID: 17183024
5. Ahsan L OA, Freeman L, Vaisman B, Amar MJ, Shamburek RD, Remaley AT (2014) Role of Lecithin: Cholesterol Acyltransferase in HDL Metabolism and Atherosclerosis. In: Komoda T, editor. The HDL Handbook (Second Edition): Biological Functions and Clinical Implications. Amsterdam: Elsevier Inc. pp. 159-194.
6. Borysiewicz LK, Soutar AK, Evans DJ, Thompson GR, Rees AJ (1982) Renal failure in familial lecithin: cholesterol acyltransferase deficiency. Q J Med 51: 411-426. PMID: 7156322
7. Imbasciati E, Paties C, Scarpioni L, Mihatsch MJ (1986) Renal lesions in familial lecithin-cholesterol acyltransferase deficiency. Ultrastructural heterogeneity of glomerular changes. Am J Nephrol 6: 66-70.
8. Sessa A, Battini G, Meroni M, Daidone G, Carnera I, et al. (2001) Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations. Nephron 88: 268-272. PMID: 11423760
9. Tsuchiya Y, Ubara Y, Hiramatsu R, Suwabe T, Hoshino J, et al. (2011) A case of familial lecithin-cholesterol acyltransferase deficiency on hemodialysis for over 20 years. Clin Nephrol 76: 492-498. PMID: 22105454
10. Weber CL, Frohlich J, Wang J, Hegele RA, Chan-Yan C (2007) Stability of lipids on peritoneal dialysis in a patient with familial LCAT deficiency. Nephrol Dial Transplant 22: 2084-2088. PMID: 17452402
11. Strom EH, Sund S, Reier-Nilsen M, Dorje C, Leren TP (2011) Lecithin: Cholesterol Acyltransferase (LCAT) Deficiency: renal lesions with early graft recurrence. Ultrastruct Pathol 35: 139-145. doi: 10. 3109/01913123.2010.551578 PMID: 21323422
12. Ritland S (1975) The abnormal "lipoprotein of cholestasis", lipoprotein-X. Scand J Gastroenterol 10: 785-789. PMID: 173014
13. O K, Frohlich J (1995) Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro. J Lipid Res 36: 2344-2354. PMID: 8656072
14. Lynn EG, Choy PC, Magil A, O K (1997) Uptake and metabolism of lipoprotein-X in mesangial cells. Mol Cell Biochem 175: 187-194. PMID: 9350051
15. O K, Ly M, Fang DZ, Frohlich J, Choy PC (1997) Effect of lipoprotein-X on lipid metabolism in rat kidney. Mol Cell Biochem 173: 17-24. PMID: 9278250
16. Lambert G, Sakai N, Vaisman BL, Neufeld EB, Marteyn B, et al. (2001) Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J Biol Chem 276: 15090-15098. PMID: 11278414
17. Zhu X, Herzenberg AM, Eskandarian M, Maguire GF, Scholey JW, et al. (2004) A novel in vivo lecithincholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy. Am J Pathol 165: 1269-1278. PMID: 15466392
18. Miarka P, Idzior-Walus B, Kuzniewski M, Walus-Miarka M, Klupa T, et al. (2011) Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency. Clin Exp Nephrol 15: 424-429. doi: 10.1007/s10157-011-0409-1 PMID: 21327698
19. Naito S, Kamata M, Furuya M, Hayashi M, Kuroda M, et al. (2013) Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment. Atherosclerosis 228: 193-197. doi: 10. 1016/j.atherosclerosis.2013.02.034 PMID: 23522979
20. Yee MS, Pavitt DV, Richmond W, Cook HT, McLean AG, et al. (2009) Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy. Atherosclerosis 205: 528-532. doi: 10.1016/j.atherosclerosis.2008.11.033 PMID: 19230892
21. Aranda P, Valdivielso P, Pisciotta L, Garcia I, Garca AAC, et al. (2008) Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). Clin Nephrol 69: 213-218. PMID: 18397721
22. Rousset X, Vaisman B, Auerbach B, Krause BR, Homan R, et al. (2010) Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice. J Pharmacol Exp Ther 335: 140-148. doi: 10.1124/jpet.110.169540 PMID: 20605907
23. Shamburek RD, Bakker-Arkema R, Shamburek AM, Freeman LA, Amar MJ, et al. (2016) Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study. Circulation Research 118: 73-82. doi: 10.1161/CIRCRESAHA.115. 306223 PMID: 26628614
24. Shamburek RD, Bakker-Arkema R, Auerbach BJ, Krause BR, Homan R, et al. (2016) Familial Lecithin: Cholesterol Acyltransferase Deficiency: First-in-Human Treatment with Enzyme Replacement. Journal of Clinical Lipidology.
25. Brewer HB Jr., Ronan R, Meng M, Bishop C (1986) Isolation and characterization of apolipoproteins AI, A-II, and A-IV. Methods Enzymol 128: 223-246. PMID: 3088390
26. Vaisman BL, Demosky SJ, Stonik JA, Ghias M, Knapper CL, et al. (2012) Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis. Journal of Lipid Research 53: 158-167. doi: 10.1194/jlr.M018713 PMID: 22039582
27. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. PMID: 18546601
28. Sakairi T, Abe Y, Kajiyama H, Bartlett LD, Howard LV, et al. (2010) Conditionally immortalized human podocyte cell lines established from urine. Am J Physiol Renal Physiol 298: F557-567. doi: 10.1152/ajprenal.00509.2009 PMID: 19955187
29. Kriz W, Shirato I, Nagata M, LeHir M, Lemley KV (2013) The podocyte's response to stress: the enigma of foot process effacement. Am J Physiol Renal Physiol 304: F333-347. doi: 10.1152/ajprenal.00478. 2012 PMID: 23235479
30. Shayman JA, Abe A (2013) Drug induced phospholipidosis: an acquired lysosomal storage disorder. Biochim Biophys Acta 1831: 602-611. doi: 10.1016/j.bbalip.2012.08.013 PMID: 22960355
31. Rubies-Prat J, Ras M. R., Frison J.C Masdeu S., Bacardi R. (1977) The clearance of lipoprotein X in vitro, and effect of phospholipase A on serum lipoprotein X. Clinica Chimica Acta 75: 117-121.
32. Scott RP, Quaggin SE (2015) Review series: The cell biology of renal filtration. J Cell Biol 209: 199-210. doi: 10.1083/jcb.201410017 PMID: 25918223
33. Argraves KM, Sethi AA, Gazzolo PJ, Wilkerson BA, Remaley AT, et al. (2011) S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis 10: 70. doi: 10.1186/1476-511X-10-70 PMID: 21554699
34. New LA, Martin CE, Jones N (2014) Advances in slit diaphragm signaling. Curr Opin Nephrol Hypertens 23: 420-430. doi: 10.1097/01.mnh.0000447018.28852.b6 PMID: 24867674
35. Abbott F, Ryan JJ, Ceska M, Matsushima K, Sarraf CE, et al. (1991) Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and-8. Kidney Int 40: 597-605. PMID: 1745007
36. Leonard M, Ryan MP, Watson AJ, Schramek H, Healy E (1999) Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Kidney Int 56: 1366-1377. PMID: 10504489
37. Steenhard BM, Vanacore R, Friedman D, Zelenchuk A, Stroganova L, et al. (2012) Upregulated expression of integrin alpha1 in mesangial cells and integrin alpha3 and vimentin in podocytes of Col4a3-null (Alport) mice. PLoS One 7: e50745. doi: 10.1371/journal.pone.0050745 PMID: 23236390
38. Zou J, Yaoita E, Watanabe Y, Yoshida Y, Nameta M, et al. (2006) Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch 448: 485-492. PMID: 16418842
39. Shamburek RD, Freeman L, Sampson M, Bakker-Arkema R, Krause B, et al. (2013) Human Enzyme Replacement Therapy in a Patient With Familial Lecithin Cholesterol Acyltransferase Deficiency: Rapid Appearance of Normal Appearing HDL. Circulation 128.
40. Nishiwaki M, Ikewaki K, Bader G, Nazih H, Hannuksela M, et al. (2006) Human lecithin:cholesterol acyltransferase deficiency: in vivo kinetics of low-density lipoprotein and lipoprotein-X. Arterioscler Thromb Vasc Biol 26: 1370-1375. PMID: 16543491
41. Haraldsson B, Nystrom J (2012) The glomerular endothelium: new insights on function and structure. Curr Opin Nephrol Hypertens 21: 258-263. doi: 10.1097/MNH.0b013e3283522e7a PMID: 22388551
42. Haraldsson BS (2014) The endothelium as part of the integrative glomerular barrier complex. Kidney Int 85: 8-11. doi: 10.1038/ki.2013.317 PMID: 24380900
43. Salmon AH, Satchell SC (2012) Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol 226: 562-574. doi: 10.1002/path.3964 PMID: 22102407
44. Obeidat M, Obeidat M, Ballermann BJ (2012) Glomerular endothelium: a porous sieve and formidable barrier. Exp Cell Res 318: 964-972. doi: 10.1016/j.yexcr.2012.02.032 PMID: 22465480
45. Kanwar YS, Farquhar MG (1979) Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol 81: 137-153. PMID: 90048
46. Tryggvason K, Patrakka J, Wartiovaara J (2006) Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354: 1387-1401. PMID: 16571882
47. Lim JP, Gleeson PA (2011) Macropinocytosis: an endocytic pathway for internalising large gulps. Immunol Cell Biol 89: 836-843. doi: 10.1038/icb.2011.20 PMID: 21423264
48. Xu C, Chang A, Hack BK, Eadon MT, Alper SL, et al. (2014) TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Kidney Int 85: 72-81. doi: 10. 1038/ki.2013.286 PMID: 23903370
49. Linder S (2007) The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 17: 107-117. PMID: 17275303
50. Murphy DA, Courtneidge SA (2011) The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 12: 413-426. doi: 10.1038/nrm3141 PMID: 21697900
51. Genot E, Gligorijevic B (2014) Invadosomes in their natural habitat. Eur J Cell Biol 93: 367-379. doi: 10.1016/j.ejcb.2014.10.002 PMID: 25457677
52. Schlondorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20: 1179-1187. doi: 10.1681/ASN.2008050549 PMID: 19470685
53. Scindia YM, Deshmukh US, Bagavant H (2010) Mesangial pathology in glomerular disease: targets for therapeutic intervention. Adv Drug Deliv Rev 62: 1337-1343. doi: 10.1016/j.addr.2010.08.011 PMID: 20828589
54. Abboud HE (2012) Mesangial cell biology. Exp Cell Res 318: 979-985. doi: 10.1016/j.yexcr.2012.02. 025 PMID: 22414873
55. Chung JJ, Huber TB, Godel M, Jarad G, Hartleben B, et al. (2015) Albumin-associated free fatty acids induce macropinocytosis in podocytes. J Clin Invest 125: 2307-2316. doi: 10.1172/JCI79641 PMID: 25915582
56. Glukhova A, Hinkovska-Galcheva V, Kelly R, Abe A, Shayman JA, et al. (2015) Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase. Nat Commun 6: 6250. doi: 10. 1038/ncomms7250 PMID: 25727495
57. Nosadini R, Tonolo G (2011) Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr Metab Cardiovasc Dis 21: 79-85. doi: 10.1016/j.numecd.2010.10.002 PMID: 21186102
58. Merscher S, Pedigo CE, Mendez AJ (2014) Metabolism, energetics, and lipid biology in the podocyte-cellular cholesterol-mediated glomerular injury. Front Endocrinol (Lausanne) 5: 169.
59. Fornoni A, Merscher S, Kopp JB (2014) Lipid biology of the podocyte-new perspectives offer new opportunities. Nat Rev Nephrol 10: 379-388. doi: 10.1038/nrneph.2014.87 PMID: 24861084